Media Coverage

The Company is pleased to announce it has received an Australian Government R&D Tax Incentive paymen...

Innovative diabetic diagnosis recognised Issue No.14 – November 2015

Proteomics International (ASX: PIQ) is pleased to announce it has been granted a US patent for its P...

ASX-release_Diagnostics-technical-update-DKD-1510261

Proteomics Technical Presentation

Proteomics International recognised for its world leading proteomics services with the Health and Bi...

Proteomics International is a global leader in the area of proteomics and has been acknowledged for ...

Proteomics International (ASX: PIQ) is pleased to announce that it has produced and validated a pred...

Proteomics International (Code: PIQ) has today confirmed the appointment of Chuck Morrison to head i...

Proteomics International (Code: PIQ) lands its largest single contract in the fast growing biosimila...

Media release

Shares in emerging life science company Proteomics International Laboratories (Code: PIQ) start trad...

Proteomics International Laboratories Ltd is pleased to announce that it has closed its IPO after ra...

The Human Genome Project represents the single largest undertaking in the history of biological scie...

Proteomics International has finalised agreement with major Chinese bio-pharmaceutical company New S...

There are two huge and overlapping trends happening in the healthcare sector – personalised medicine...

PILL has issued a Supplementary Prospectus following execution of an agreement to commercialise its ...